GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Ellis, L. [1 ]
Bolge, S. [1 ]
Rice, P. [2 ]
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] Premier Res, Naperville, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1067
引用
收藏
页码：1154 / 1154
页数：1
相关论文
共 50 条
  • [1] GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ellis, L.
    Bolge, S.
    Rice, P.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A49 - A50
  • [2] PATIENT CHARACTERISTICS AND GOLIMUMAB UTILIZATION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Bolge, S.
    Gunnarsson, C.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A48 - A48
  • [3] Golimumab In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Oldfield, Vicki
    Plosker, Greg L.
    [J]. BIODRUGS, 2009, 23 (02) : 125 - 135
  • [4] Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini, M.
    Viapiana, O.
    Orsolini, G.
    Fracassi, E.
    Idolazzi, L.
    Gatti, D.
    Adami, S.
    Govoni, M.
    [J]. REUMATISMO, 2014, 66 (04) : 285 - 303
  • [5] The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Furst, Daniel E.
    Kay, Jonathan
    Wasko, Mary Chester
    Keystone, Edward
    Kavanaugh, Arthur
    Deodhar, Atul
    Murphy, Frederick T.
    Magnus, Jeanette H.
    Hsia, Elizabeth C.
    Hsu, Benjamin
    Xu, Stephen
    Rahman, Mahboob U.
    Doyle, Mittie K.
    [J]. RHEUMATOLOGY, 2013, 52 (10) : 1845 - 1855
  • [6] Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    [J]. Drugs & Therapy Perspectives, 2010, 26 (4) : 1 - 4
  • [7] Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Leu, Jocelyn H.
    Adedokun, Omoniyi J.
    Gargano, Cynthia
    Hsia, Elizabeth C.
    Xu, Zhenhua
    Shankar, Gopi
    [J]. RHEUMATOLOGY, 2019, 58 (03) : 441 - 446
  • [8] A QUANTITATIVE ASSESSMENT OF ADHERENCE TO DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Raghunath, S.
    Dissanayake, K.
    Goldblatt, F.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 17 - 17
  • [9] Golimumab: a new anti-TNF-α agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Voulgari, Paraskevi V.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 721 - 733
  • [10] Golimumab improves socio economic and health economic parameters in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Krueger, Klaus
    Burmester, Gerd Ruediger
    Wassenberg, Siegfried
    Thomas, Matthias H.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1559 - 1567
12345